Alina N. West
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alina N. West has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Adrienne G. Randolph
Department of Anaesthesia and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA
2 shared publications Danielle Severns
Department of Pediatrics, University of Tennessee Health Science Center, Memphis, USA
2 shared publications- Emma Kaitlynn Allen
St. Jude Children's Research Hospital
2 shared publications Granger Ridout
Hartwell Center for Biotechnology, St. Jude Children’s Research Hospital, Memphis, USA
2 shared publications- Jeremy Chase Crawford
Department of Host-Microbe Interactions, St. Jude Children’s Research Hospital, Memphis, USA
2 shared publications - Paul Glyndwr Thomas
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, USA
2 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (8) , 1580-1585
Evaluation of cardiac abnormalities in multi-system inflammatory syndrome in children related multi-organ dysfunction syndrome
Introduction: Multi-system inflammatory syndrome in children hyperinflammation can cause multiple organ system dysfunction syndrome through mechanisms, including endothelial dysfunction and thrombotic microangiopathy. We evaluated potential endothelial damage and thrombotic microangiopathy as an underlying multi-system inflammatory syndrome in children associated multi-organ dysfunction syndrome pathophysiology. Cardiac dysfunction was assessed using echocardiogram and copeptin. Methods: In pediatric ICU multi-system inflammatory syndrome in children patients, multi-organ dysfunction syndrome and thrombotic microangiopathy criteria were established using medical record data. Terminal complement and copeptin levels were evaluated alongside imaging (including echocardiogram), blood work, signs and symptoms of multi-organ dysfunction syndrome, and interventions documented during hospitalisation. Copeptin level correlation with multi-organ dysfunction syndrome severity and biomarkers of cardiac dysfunction were analysed. Results: Of 12 pediatric ICU patients with multi-system inflammatory syndrome in children, 7 (58.33%) patients met multi-organ dysfunction syndrome criteria, and 8 (66.67%) met thrombotic microangiopathy criteria. Renal (66.67%) and cardiovascular (58.33%) dysfunction were most associated with multi-organ dysfunction syndrome. Multi-system inflammatory syndrome in children patients had higher terminal complement and copeptin levels compared to eight control subjects. Copeptin had a significant negative relationship with left ventricular ejection fraction and positive relationships with B-type natriuretic peptide and blood urea nitrogen but no other markers of renal or cardiac dysfunction. There was a strong positive relationship between copeptin and terminal complement. Conclusion: Multi-system inflammatory syndrome in children requiring pediatric ICU admission are multi-organ dysfunction syndrome-susceptible due to underlying complement-associated thrombotic microangiopathy. Copeptin can be used as a marker of acute critical illness and systolic dysfunction in multi-system inflammatory syndrome in pediatric patients. These biomarkers would guide clinicians earlier in the diagnosis and treatment of thrombotic microangiopathy-related multi-organ dysfunction syndrome due to multi-system inflammatory syndrome in children. However, their utility as markers for myocardial injury, diastolic dysfunction, and the severity of multi-organ dysfunction syndrome needs further evaluation.
- 27 July 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (8) , 1580-1585
Open AccessEvaluation of cardiac abnormalities in multi-system inflammatory syndrome in children related multi-organ dysfunction syndrome
Introduction: Multi-system inflammatory syndrome in children hyperinflammation can cause multiple organ system dysfunction syndrome through mechanisms, including endothelial dysfunction and thrombotic microangiopathy. We evaluated potential endothelial damage and thrombotic microangiopathy as an underlying multi-system inflammatory syndrome in children associated multi-organ dysfunction syndrome pathophysiology. Cardiac dysfunction was assessed using echocardiogram and copeptin. Methods: In pediatric ICU multi-system inflammatory syndrome in children patients, multi-organ dysfunction syndrome and thrombotic microangiopathy criteria were established using medical record data. Terminal complement and copeptin levels were evaluated alongside imaging (including echocardiogram), blood work, signs and symptoms of multi-organ dysfunction syndrome, and interventions documented during hospitalisation. Copeptin level correlation with multi-organ dysfunction syndrome severity and biomarkers of cardiac dysfunction were analysed. Results: Of 12 pediatric ICU patients with multi-system inflammatory syndrome in children, 7 (58.33%) patients met multi-organ dysfunction syndrome criteria, and 8 (66.67%) met thrombotic microangiopathy criteria. Renal (66.67%) and cardiovascular (58.33%) dysfunction were most associated with multi-organ dysfunction syndrome. Multi-system inflammatory syndrome in children patients had higher terminal complement and copeptin levels compared to eight control subjects. Copeptin had a significant negative relationship with left ventricular ejection fraction and positive relationships with B-type natriuretic peptide and blood urea nitrogen but no other markers of renal or cardiac dysfunction. There was a strong positive relationship between copeptin and terminal complement. Conclusion: Multi-system inflammatory syndrome in children requiring pediatric ICU admission are multi-organ dysfunction syndrome-susceptible due to underlying complement-associated thrombotic microangiopathy. Copeptin can be used as a marker of acute critical illness and systolic dysfunction in multi-system inflammatory syndrome in pediatric patients. These biomarkers would guide clinicians earlier in the diagnosis and treatment of thrombotic microangiopathy-related multi-organ dysfunction syndrome due to multi-system inflammatory syndrome in children. However, their utility as markers for myocardial injury, diastolic dysfunction, and the severity of multi-organ dysfunction syndrome needs further evaluation.
- Open Access
- 15 May 2025
- Published by IOS Press
- Vol. 327, 1469-1470
Achieving SDoH Resource Equity in PICU Using an AI-Enabled Patient Navigator
Trauma care coordination in the pediatric intensive care unit (PICU), including personalization of resources based on social determinants of health (SDoH), is challenging for already strained healthcare providers. Patient SDoH data collection is inconsistent, fragmented, and lacks standardization during hospitalization, complicating resource allocation and usability for both patients and providers. We propose implementing AI tools to standardize SDoH data collection and enhance resource navigation for patients and providers during and after trauma hospitalization. We will use the RE-AIM Framework to initially evaluate the reach and effectiveness of the individual tools and overall process, including user-friendliness and the percentage of resource allocation and utilization.
- 15 May 2025
- Published by IOS Press
- Vol. 327, 1469-1470
Open AccessAchieving SDoH Resource Equity in PICU Using an AI-Enabled Patient Navigator
Trauma care coordination in the pediatric intensive care unit (PICU), including personalization of resources based on social determinants of health (SDoH), is challenging for already strained healthcare providers. Patient SDoH data collection is inconsistent, fragmented, and lacks standardization during hospitalization, complicating resource allocation and usability for both patients and providers. We propose implementing AI tools to standardize SDoH data collection and enhance resource navigation for patients and providers during and after trauma hospitalization. We will use the RE-AIM Framework to initially evaluate the reach and effectiveness of the individual tools and overall process, including user-friendliness and the percentage of resource allocation and utilization.
- Open Access
- 30 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS), termed pediatric ARDS (pARDS) in children, is a severe form of acute respiratory failure (ARF). Pathologic immune responses are implicated in pARDS pathogenesis. Here, we present a description of microbial sequencing and single cell gene expression in tracheal aspirates (TAs) obtained longitudinally from infants with ARF. We show reduced interferon stimulated gene (ISG) expression, altered mononuclear phagocyte (MNP) transcriptional programs, and progressive airway neutrophilia associated with unique transcriptional profiles in patients with moderate to severe pARDS compared to those with no or mild pARDS. We additionally show that an innate immune cell product, Folate Receptor 3 (FOLR3), is enriched in moderate or severe pARDS. Our findings demonstrate distinct inflammatory responses in pARDS that are dependent upon etiology and severity and specifically implicate reduced ISG expression, altered macrophage repair-associated transcriptional programs, and accumulation of aged neutrophils in the pathogenesis of moderate to severe pARDS caused by RSV.
- 30 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Open AccessSingle cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS), termed pediatric ARDS (pARDS) in children, is a severe form of acute respiratory failure (ARF). Pathologic immune responses are implicated in pARDS pathogenesis. Here, we present a description of microbial sequencing and single cell gene expression in tracheal aspirates (TAs) obtained longitudinally from infants with ARF. We show reduced interferon stimulated gene (ISG) expression, altered mononuclear phagocyte (MNP) transcriptional programs, and progressive airway neutrophilia associated with unique transcriptional profiles in patients with moderate to severe pARDS compared to those with no or mild pARDS. We additionally show that an innate immune cell product, Folate Receptor 3 (FOLR3), is enriched in moderate or severe pARDS. Our findings demonstrate distinct inflammatory responses in pARDS that are dependent upon etiology and severity and specifically implicate reduced ISG expression, altered macrophage repair-associated transcriptional programs, and accumulation of aged neutrophils in the pathogenesis of moderate to severe pARDS caused by RSV.
- Open Access
- 8 September 2022
- Published by Springer Nature in Research Square
Single Cell Analysis Identifies Distinct Profiles in Pediatric Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS), termed pediatric ARDS (pARDS) in children, is a severe form of acute respiratory failure (ARF) that is associated with significant morbidity and mortality. Pathologic immune responses have been implicated in the development of pARDS. Here, we present a unique description of microbial sequencing and single cell gene expression in tracheal aspirates (TAs) obtained longitudinally from infants admitted to the pediatric intensive care unit (PICU) with ARF. Important alterations in TA epithelial cell, mononuclear phagocyte (MNP), and neutrophil transcription were associated with subjects’ illness severity, etiology (of ARF), and sampling time point. Specifically, in patients with moderate to severe pARDS compared to those with no to mild pARDS we identified reduced interferon stimulated gene (ISG) and cytokine expression in epithelial cells, reduced development over time of a regulatory IL-10 expressing macrophage population, and progressive airway neutrophilia associated with a unique transcriptional profile in aged neutrophils. In addition, we incorporated viral capture sequencing (ViroCap) with single cell transcriptomic analysis to explore interactions between respiratory syncytial virus (RSV) and host cells in infected and bystander epithelia. Our findings indicate that pARDS is defined by distinct inflammatory cell profiles that are etiology- and severity-dependent and implicate inadequate induction of ISGs, cytokines/chemokines, and repair-associated macrophage transcriptional programs in the pathogenesis of moderate to severe pARDS.
- 8 September 2022
- Published by Springer Nature in Research Square
Open AccessSingle Cell Analysis Identifies Distinct Profiles in Pediatric Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS), termed pediatric ARDS (pARDS) in children, is a severe form of acute respiratory failure (ARF) that is associated with significant morbidity and mortality. Pathologic immune responses have been implicated in the development of pARDS. Here, we present a unique description of microbial sequencing and single cell gene expression in tracheal aspirates (TAs) obtained longitudinally from infants admitted to the pediatric intensive care unit (PICU) with ARF. Important alterations in TA epithelial cell, mononuclear phagocyte (MNP), and neutrophil transcription were associated with subjects’ illness severity, etiology (of ARF), and sampling time point. Specifically, in patients with moderate to severe pARDS compared to those with no to mild pARDS we identified reduced interferon stimulated gene (ISG) and cytokine expression in epithelial cells, reduced development over time of a regulatory IL-10 expressing macrophage population, and progressive airway neutrophilia associated with a unique transcriptional profile in aged neutrophils. In addition, we incorporated viral capture sequencing (ViroCap) with single cell transcriptomic analysis to explore interactions between respiratory syncytial virus (RSV) and host cells in infected and bystander epithelia. Our findings indicate that pARDS is defined by distinct inflammatory cell profiles that are etiology- and severity-dependent and implicate inadequate induction of ISGs, cytokines/chemokines, and repair-associated macrophage transcriptional programs in the pathogenesis of moderate to severe pARDS.